Dexcom's €300M CGM manufacturing facility in Athenry, Ireland on track for 2026

Dexcom is building a state-of-the-art continuous glucose monitoring manufacturing facility in Athenry, Co Galway, Ireland, representing a €300 million investment over five years. The facility will create approximately 1,000 jobs and is on target for completion in 2026.

“With the continued success of our Dexcom G7 in Europe, we are pursuing an ambitious growth strategy that requires increased manufacturing capacity to support our rapidly expanding European user base.”businesspost.ie

• 1 source
• businesspost.ieProgress on major Dexcom facility on target for 2026 | Business PostPenny GrayOct 25, 2024

Summarized from public sources; check the original articles before acting on it.